| Cassidy Weiheng Tang, MD | |
|
6161 S Yale Ave, Tulsa, OK 74136-1902 | |
| (918) 502-1902 | |
| (918) 494-6303 |
| Full Name | Cassidy Weiheng Tang |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 7 Years |
| Location | 6161 S Yale Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275069320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35615 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warren Clinic Inc | 8820900293 | 604 |
News Archive
A team of researchers have tested everything from t-shirts and socks to jeans and vacuum bags to determine what type of mask material is most effective at trapping the ultrafine particles which may contain viruses such as SARS-CoV-2, the virus which causes COVID-19.
Teva Pharmaceutical Industries Ltd. announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.
The Monash Vision Groupmoves a step closer to clinical trials of its Bionic Eye, thanks to landmark donations from two respected business leaders.
Nonsense mutations are single-letter errors in the genetic code that prematurely halt the production of critical proteins. These unfinished proteins are unable to function normally, and nonsense mutations cause 10-15 percent of all inherited genetic diseases, including Duchenne muscular dystrophy, spinal muscular atrophy, cystic fibrosis and polycystic kidney disease.
Inova Labs, Inc. of Austin, Texas announced today the closing of the private placement of shares of its Series A Preferred Stock. The placement went to investment funds affiliated with Three Arch Partners, based in Silicon Valley, California. Inova received gross proceeds of $10.0 million from the equity financing, which will be used for nationwide and international sales expansion of its LifeChoice® portable oxygen concentrator product line, continuation of next stage developments, and working capital.
› Verified 9 days ago
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
A team of researchers have tested everything from t-shirts and socks to jeans and vacuum bags to determine what type of mask material is most effective at trapping the ultrafine particles which may contain viruses such as SARS-CoV-2, the virus which causes COVID-19.
Teva Pharmaceutical Industries Ltd. announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.
The Monash Vision Groupmoves a step closer to clinical trials of its Bionic Eye, thanks to landmark donations from two respected business leaders.
Nonsense mutations are single-letter errors in the genetic code that prematurely halt the production of critical proteins. These unfinished proteins are unable to function normally, and nonsense mutations cause 10-15 percent of all inherited genetic diseases, including Duchenne muscular dystrophy, spinal muscular atrophy, cystic fibrosis and polycystic kidney disease.
Inova Labs, Inc. of Austin, Texas announced today the closing of the private placement of shares of its Series A Preferred Stock. The placement went to investment funds affiliated with Three Arch Partners, based in Silicon Valley, California. Inova received gross proceeds of $10.0 million from the equity financing, which will be used for nationwide and international sales expansion of its LifeChoice® portable oxygen concentrator product line, continuation of next stage developments, and working capital.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cassidy Weiheng Tang, MD 6600 S Yale Ave Ste 1200, Tulsa, OK 74136-3333 Ph: (918) 488-6653 | Cassidy Weiheng Tang, MD 6161 S Yale Ave, Tulsa, OK 74136-1902 Ph: (918) 502-1902 |
News Archive
A team of researchers have tested everything from t-shirts and socks to jeans and vacuum bags to determine what type of mask material is most effective at trapping the ultrafine particles which may contain viruses such as SARS-CoV-2, the virus which causes COVID-19.
Teva Pharmaceutical Industries Ltd. announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.
The Monash Vision Groupmoves a step closer to clinical trials of its Bionic Eye, thanks to landmark donations from two respected business leaders.
Nonsense mutations are single-letter errors in the genetic code that prematurely halt the production of critical proteins. These unfinished proteins are unable to function normally, and nonsense mutations cause 10-15 percent of all inherited genetic diseases, including Duchenne muscular dystrophy, spinal muscular atrophy, cystic fibrosis and polycystic kidney disease.
Inova Labs, Inc. of Austin, Texas announced today the closing of the private placement of shares of its Series A Preferred Stock. The placement went to investment funds affiliated with Three Arch Partners, based in Silicon Valley, California. Inova received gross proceeds of $10.0 million from the equity financing, which will be used for nationwide and international sales expansion of its LifeChoice® portable oxygen concentrator product line, continuation of next stage developments, and working capital.
› Verified 9 days ago
Prasoon Kumar Yendluri, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-502-1900 Fax: 918-494-6303 | |
Janet Elizabeth Cheek, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Edie Ann Carey, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Dr. Brandon Micheal Bailey, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2811 E 15th St Ste 102, Tulsa, OK 74104 Phone: 918-935-3240 Fax: 918-935-3241 | |
Kendra Wilson, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-502-1900 Fax: 918-494-6303 | |
Radhika Kothakota, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-488-6045 Fax: 918-488-6098 | |
Dr. Gulshan Dangol, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave Ste 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 |